critical care,2006;10:R79
Design: Prospective, multiple-center cohort study Setting: 3 European ICU having expertise with NPPV Patients: Between March 2002 and April 2004 479 patients with ARDS were admitted to the ICU 332 ARDS patients were already intubated 147 were eligible for the study
Mwbazaa A, et al. Crit Care Med, 2008, 36 :S129–S139
无创正压通气应为AHF的一线治疗手段!
无创正压通气治疗AHF指证:应用时机
无禁忌证 尽早应用
较明显呼吸困难或/和缺氧表现而常规氧疗效果不 佳
对伴有CO2潴留者应不失时机
男性,45岁,肾移植术后3月,PCP
Shock: all 19 pats with shock failed to NPPV Metabolic acidosis:7.37 (7.26–7.43) vs 7.39 (7.32–7.45) Severe hypoxemia:112 (70–157) vs 147 (118–209)
9-6
9-7
男性,45岁, PCP,肾移植术后3月
9-20
最终死于VAP以及气压伤
04-9-27
04-9-28
文献复习:免疫抑制患者行有创通气的存活率
有创通气病死率高
系统回顾(System review)
干细胞移植术后接受IPPV的患者病死可能性: